Almirall, Lundbeck Sign Accord To Market Antidepressant in Italy

Almirall SA (ALM) signed an accord with H. Lundbeck A/S to market the antidepressant escitalopram in Italy, the Barcelona-based company said in a regulatory filing today. Almirall expects to get revenue as soon as this year from the treatment, to be sold under the brand Cipralex, it said.

To contact the editor responsible for this story: Manuel Baigorri at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.